When Eli Lilly Pivots, TMED’s Strategy Wins
Eli Lilly announced $3.83 billion push into vaccine acquisitions as TMED rose to top T. Rowe Price's ETF lineup last week.
America Forever Bytes
Other
Eli Lilly announced $3.83 billion push into vaccine acquisitions as TMED rose to top T. Rowe Price's ETF lineup last week.